Endovascular stenting in malignant obstruction of superior vena cava.

Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome. Springerplus (2016) 0.82

Tumors of the mediastinum. Chest (2005) 5.12

The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore) (2006) 2.80

Cryoprobe biopsy increases the diagnostic yield in endobronchial tumor lesions. J Thorac Cardiovasc Surg (2010) 1.96

Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol (2011) 1.86

Superior vena cava syndrome in thoracic malignancies. Respir Care (2011) 1.52

Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review. Clin Oncol (R Coll Radiol) (2002) 1.50

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2011) 1.48

Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. AJR Am J Roentgenol (2001) 1.47

Superior vena caval obstruction. Is it a medical emergency? Am J Med (1981) 1.33

Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J Vasc Interv Radiol (1997) 1.29

Approach to the patient who presents with superior vena cava obstruction. Chest (1993) 1.11

Fatal pericardial tamponade after superior vena cava stenting. Cardiovasc Intervent Radiol (2008) 0.96

Pacemaker-induced superior vena cava syndrome: a case report and review of management strategy. Can J Cardiol (2002) 0.95

Percutaneous treatment of superior vena cava syndrome using metallic stents. Eur Radiol (2002) 0.92